MiMedx Group, Inc. to Present at the Sidoti & Company Semiannual New York Micro-Cap Conference

Friday, June 11, 2010 Corporate News
Email Print This Page Comment
Font : A-A+



MARIETTA, Ga., June 10 MiMedx Group, Inc. (OTC Bulletin Board: MDXG), an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today that it will present at the Sidoti & Company Semiannual New York Micro-Cap Conference in New York. Parker H. "Pete" Petit, Chairman and CEO, William C. Taylor, President and COO, and Michael J. Senken, CFO of MiMedx, are scheduled to present on Friday, June 25, at 10:40 a.m. Eastern Time at the Grand Hyatt, 109 East 42nd Street at Grand Central Terminal, New York, New York. This presentation will be available on the Company's website, www.mimedx.com beginning the morning of the conference.

About the Company

MiMedx Group, Inc. ("MiMedx Group") is an integrated developer, manufacturer and marketer of patent protected biomaterial-based products. The company is successfully emerging from a development-focused start-up into a fully integrated operating company with an experienced team poised to capitalize on its science and technology to generate rapid sales growth and profitability. Our mantra is "Repair, don't replace" because our biochemists, engineers, designers and physicians believe it is better to augment repair when possible rather than replace traumatized, but otherwise healthy tissues and structures. Our platform technologies, HydroFix(TM) and CollaFix(TM), have a vast number of potential applications in treating traumatized tissue and structures and we are focused on commercializing multiple applications of both technologies. In parallel, we are seeking strategic relationships, in selective categories, to more rapidly commercialize our technologies. HydroFix(TM) and CollaFix(TM) are trademarks of MiMedx Group, Inc.

SOURCE MiMedx Group, Inc.


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook